Tag: cisplatin hearing loss

All

The Phase 2 PROHEAR trial is evaluating ACOU085 (Bimokalner) for its efficacy in protecting hearing during chemotherapy.

A study found that 78% of testicular cancer survivors treated with cisplatin-based chemotherapy experience significant hearing difficulties.